Sunzen Group Berhad (KLSE:SUNZEN)

Market Cap	208.38M
Revenue (ttm)	95.12M
Net Income (ttm)	6.03M
Shares Out	771.79M
EPS (ttm)	0.01
PE Ratio	36.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	699,900
Average Volume	422,125
Open	0.2600
Previous Close	0.2600
Day's Range	0.2600 - 0.2700
52-Week Range	0.2600 - 0.4000
Beta	0.68
RSI	43.86
Earnings Date	May 23, 2025

About Sunzen Group Berhad

Sunzen Group Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through three segments: Animal Health, Human Health, and Loan Financing. The company provides veterinary machines, pharmaceutical, chemical products, animal health products and equipment, laboratory services, and beauty and cosmetic products. It also manufactures and sells traditional Chinese medicine, herbal health foods, beverages, and other p...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2024, Sunzen Group Berhad's revenue was 95.12 million, a decrease of -3.07% compared to the previous year's 98.13 million. Earnings were 6.03 million, a decrease of -11.35%.